Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
References in this report (this “Quarterly
Report”) to “we,” “us” or the “Company” refer to Redwoods Acquisition Corp. References to our
“management” or our “management team” refer to our officers and directors. The following discussion and analysis
of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial
statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis
set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and
Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are not historical facts and involve
risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other
than statements of historical fact included in this Quarterly Report, including, without limitation, statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding the search for an initial business combination,
the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking
statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,”
“seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently
available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and
results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s
final prospectus for its initial public offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s
filings with the SEC can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable
securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result
of new information, future events or otherwise.
Overview
We are a blank check company incorporated in Delaware
on March 16, 2021. We were formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination with one or more target businesses, which we refer to herein as our “initial
business combination.” Our efforts to identify a prospective target business are not limited to any particular industry or geographic
region, although we intend to focus on the carbon neutral and energy storage industries. We intend to utilize cash derived from the proceeds
of our initial public offering (“IPO” as defined below) and the private placement of Private Units (as defined below), our
securities, debt or a combination of cash, securities and debt, in effecting our initial business combination.
The issuance of additional shares of capital stock
in connection with our initial business combination:
● may significantly dilute the equity interest
of our stockholders who would not have pre-emption rights in respect of any such issuance;
● may subordinate the rights of holders of shares
of common stock if we issue shares of preferred stock with rights senior to those afforded to our shares of common stock;
● could cause a change in control if a substantial
number of our shares of common stock are issued, which may affect, among other things, our ability to use our net operating loss carry
forwards, if any, and could result in the resignation or removal of our present officers and directors;
● may have the effect of delaying or preventing
a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and
● may adversely affect prevailing market prices
for our securities.
16
Similarly, if we issue debt securities or otherwise
incur significant debt, it could result in:
● default
and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
● acceleration of our obligations to repay the
indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance
of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
● our immediate payment of all principal and accrued
interest, if any, if the debt security is payable on demand;
● our inability to obtain necessary additional financing if the debt security contains covenants restricting
our ability to obtain such financing while the debt security is outstanding;
● using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce
the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions,
and fund other general corporate purposes;
● limitations on our flexibility in planning for and reacting to changes in our business and in the industry
in which we operate;
● increased vulnerability to adverse changes in general economic, industry and competitive conditions and
adverse changes in government regulation; and
● limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions,
debt service requirements, execution of our strategy, and other purposes and other disadvantages compared to our competitors who have
less debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an initial business combination will be successful.
Results of Operations
We have neither engaged in any operations nor
generated any operating revenues to date. Our only activities through March 31, 2022 were organizational activities and those necessary
to prepare for our IPO, which is described below, and subsequent to the IPO, identifying a target company for an initial business combination.
We do not expect to generate any operating revenues until after the completion of our initial business combination. We generate non-operating
income in the form of interest income on cash and cash equivalents held in the Trust Account, which is described below. There has been
no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial
statements. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance),
as well as for due diligence expenses in connection with searching for, and completing, an initial business combination.
For the three months ended March 31, 2022, we
had a net loss of $5,010, all of which were derived from general and administrative expenses.
Liquidity and Capital Resources
On April 4, 2022, we completed our initial public
offering (“IPO”) of 10,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $100,000,000.
Each Unit consisted of one share of common stock, par value $0.0001, one redeemable warrant and one right to receive one-tenth (1/10)
of a share of common stock upon the consummation of an initial business combination. Simultaneously with the closing of the IPO, we completed
the sale of 477,500 units (the “Private Units”) in a private placement, at a price of $10.00 per Private Unit, generating
gross proceeds of $4,775,000. The Private Units are identical to the Units sold in the IPO, except that the private warrants will be non-redeemable
and may be exercised on a cashless basis, in each case so long as they continue to be held by their initial purchasers or their permitted
transferees.
17
Simultaneously with the closing of the IPO, we
issued to Chardan Capital Markets, LLC (“Chardan”), the representative of the underwriters, for an aggregate of $100.00, an
option (the “UPO”) to purchase up to 345,000 Units. The UPO is exercisable at any time, in whole or in part, commencing on
the later of the consummation of the initial business combination and six months from the date of the prospectus for the IPO and expiring
on the fifth anniversary of the date of the prospectus, at a price of $11.50 per Unit.
We
granted the underwriters in the IPO a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments, if any. On
April 5, 2022 , the underwriters fully exercised the over-allotment option
and, on April 7, 2022 , purchased an additional 1,500,000 Units (the “Over-Allotment
Units”), at a price of $10.00 per Unit, generating gross proceeds of $15,000,000 .
Simultaneously with the closing of the exercise of the over-allotment option, we consummated the sale of 52,500 Private Units (the “Over-Allotment
Private Units”) in a private placement, at a purchase price of $10.00 per Private Unit, generating gross proceeds of $525,000 .
Following
the IPO and the private placement (including the Over-Allotment Units and the Over-Allotment
Private Units ) , a total of $116,150,000 was
placed in a trust account located in the United States established for the benefit of the Company’s public stockholders (the
“Trust Account”). We incurred $8,365,339 of transaction costs, consisting of $2,875,000 of underwriting fees, $4,312,500 of
deferred underwriting fees (payable only upon completion of an initial business combination) and $1,177,839 of other offering costs.
We intend to use substantially all of the net
proceeds of the IPO and the private placement, including the funds held in the Trust Account, in connection with our initial business
combination and to pay our expenses relating thereto, including deferred underwriting discounts and commissions payable to the underwriters
in the IPO in an amount equal to 3.75% of the total gross proceeds raised in the IPO upon consummation of our initial business combination.
To the extent that our capital stock is used in whole or in part as consideration to effect our initial business combination, the remaining
proceeds held in the Trust Account as well as any other net proceeds not expended will be used as working capital to finance the operations
of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’
operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also
be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination
if the funds available to us outside of the Trust Account were insufficient to cover such expenses.
We believe that, upon consummation of the IPO
and the private placement, the $1,215,100 of net proceeds not held in the Trust Account will be sufficient to allow us to operate for
at least the next 12 months (or up to 18 months if our time to complete an initial business combination is extended), assuming that an
initial business combination is not consummated during that time. Over this time period, we will be using these funds for identifying
and evaluating prospective business combination candidates, performing business due diligence on prospective target businesses, traveling
to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements
of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the initial business
combination.
In order to finance transaction costs in connection
with searching for a target business or consummating the initial business combination, our initial stockholders, officers, directors or
their affiliates may, but are not obligated to, loan us funds as may be required. In the event that the initial business combination does
not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from
the Trust Account would be used for such repayment. Such loans would be evidenced by promissory notes. The notes would either be paid
upon consummation of our initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes
may be converted upon consummation of the initial business combination into units at a price of $10.00 per unit. The units would be identical
to the Private Units. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans.
18
We do not believe we will need to raise additional
funds following the IPO in order to meet the expenditures required for operating our business. However, if our estimates of the costs
of identifying a target business, undertaking in-depth due diligence and negotiating our initial business combination are less than the
actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination.
Moreover, we may need to obtain additional financing either to consummate our initial business combination or because we become obligated
to redeem a significant number of our public shares upon consummation of our initial business combination, in which case we may issue
additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws,
we would only consummate such financing simultaneously with the consummation of our initial business combination. If we are unable to
complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations
and liquidate the Trust Account. In addition, following our initial business combination, if cash on hand is insufficient, we may need
to obtain additional financing in order to meet our obligations.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of March 31, 2022. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
Promissory Notes – Related Party
On January 4, 2022 and February 28, 2022, Redwoods
Capital LLC (the “Sponsor”) agreed to loan us up to an aggregate amount of $200,000 to be used, in part, for transaction costs
incurred in connection with the IPO (the “Promissory Notes”). The Promissory Notes were unsecured, interest-free and due on
the closing the IPO. As of March 31, 2022, there were $200,000 outstanding under the Promissory Notes. The outstanding balance under the
Promissory Notes was repaid on April 7 and April 8, 2022.
Administrative Services Agreement
We have entered into an administrative services
agreement pursuant to which we will pay the Sponsor a total of $10,000 per month (subject to deferral as described herein) for office
space, utilities, secretarial and administrative support services. Upon completion of our initial business combination or our liquidation,
we will cease paying these monthly fees.
Underwriting Agreement
Pursuant to an underwriting agreement in connection
with the IPO, we granted the underwriters a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments at the
IPO price, less the underwriting discounts and commissions. On April 7, 2022, the underwriters fully exercised the over-allotment option
to purchase an additional 1,500,000 Units at an offering price of $10.00 per Unit for an aggregate purchase price of $15,000,000.
The underwriters were paid a cash underwriting
discount of $0.25 per unit, or $2,875,000 in the aggregate, upon the closing of the IPO and full exercise of the over-allotment option.
In addition, $0.375 per unit, or $4,312,500 in the aggregate, will be payable to the underwriters for deferred underwriting commissions.
The deferred commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we
complete an initial business combination, subject to the terms of the underwriting agreement.
19
Right of First Refusal
Subject to certain conditions, we granted Chardan,
for a period of 18 months after the date of the consummation of our initial business combination, a right of first refusal to act as book-running
manager, with at least 30% of the economics, for any and all future public and private equity and debt offerings by us or any of our successors
or subsidiaries. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three
years from the commencement of sales of this offering.
Critical Accounting Policies
The preparation of condensed financial statements
and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities
at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from
those estimates. We have identified the following critical accounting policies:
Common Stock Subject to Possible Redemption
We
account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”)
Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability
instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that
are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control)
is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features
certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly,
common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity
section of our condensed balance sheets. We recognize changes in redemption value immediately as they occur and adjusts the carrying
value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying
amount of shares of redeemable common stock are affected by charges against additional paid in capital or accumulated deficit if additional
paid in capital equals to zero.
Net Income (Loss) Per Share
The Company complies with accounting and disclosure
requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares
and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable
shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. We then allocated the undistributed
income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any
re-measurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends
paid to the public shareholders.
Offering Costs
Offering costs were consisting
principally of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are related to the IPO
and were charged to stockholders’ equity upon the completion of the IPO. The Company allocates offering costs between public shares
and public rights based on the relative fair values of public shares and public rights.
20
Recent Accounting Standards
In August
2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and
Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s
Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models
required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the
derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective
for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted.
We adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have an impact on our financial statements.
Management does not believe that any other recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market
Risk
As a smaller reporting company, we are not required
to make disclosures under this Item.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.